Informed Consent
Item
the patient must have given her informed and signed consent
boolean
C0021430 (UMLS CUI [1])
Patient is insured Health insurance plan | Insurance Beneficiary Health insurance plan
Item
the patient must be insured or beneficiary of a health insurance plan
boolean
C1548651 (UMLS CUI [1,1])
C0679933 (UMLS CUI [1,2])
C3853043 (UMLS CUI [2,1])
C0679933 (UMLS CUI [2,2])
Patient Available Follow-up
Item
the patient is available for 10 months of follow-up
boolean
C0030705 (UMLS CUI [1,1])
C0470187 (UMLS CUI [1,2])
C3274571 (UMLS CUI [1,3])
Pregnancy | Consultation Before Amenorrhea | Risk factors Quantity | Age | Body mass index | Family history of diabetes mellitus type 2 | Gestational Diabetes | Macrosomia
Item
the patient is pregnant and consulting before 24 weeks of amenorrhea and has at least one of the following risk factors: age > 35 years; body mass index > 25; family history of type 2 diabetes; history of gestational diabetes; history of macrosomia.
boolean
C0032961 (UMLS CUI [1])
C0009818 (UMLS CUI [2,1])
C0332152 (UMLS CUI [2,2])
C0002453 (UMLS CUI [2,3])
C0035648 (UMLS CUI [3,1])
C1265611 (UMLS CUI [3,2])
C0001779 (UMLS CUI [4])
C1305855 (UMLS CUI [5])
C2316287 (UMLS CUI [6])
C0085207 (UMLS CUI [7])
C0158915 (UMLS CUI [8])
Fasting blood glucose measurement | Status pre- Amenorrhea | Oral Glucose Tolerance Test Abnormal
Item
the patient has a fasting blood glucose level >= 0.92 g/l before 24 weeks of amenorrhea or a fasting blood glucose level < 0.92 g/l before 24 weeks of amenorrhea and an abnormal oral glucose tolerance test (75 g of glucose) between 24 and 28 weeks of amenorrhea (normal values are set at t0 < 0.92 g/l; t60 < 1.80 g/l; t120 < 1.53 g/l).
boolean
C0428568 (UMLS CUI [1])
C0332152 (UMLS CUI [2,1])
C0002453 (UMLS CUI [2,2])
C0029161 (UMLS CUI [3,1])
C0205161 (UMLS CUI [3,2])
Study Subject Participation Status
Item
the patient is participating in another study
boolean
C2348568 (UMLS CUI [1])
Study Subject Participation Status | Exclusion Period
Item
the patient is in an exclusion period determined by a previous study
boolean
C2348568 (UMLS CUI [1])
C2828389 (UMLS CUI [2,1])
C1948053 (UMLS CUI [2,2])
Guardianship
Item
the patient is under judicial protection, under tutorship or curatorship
boolean
C0870627 (UMLS CUI [1])
Informed Consent Refused
Item
the patient refuses to sign the consent
boolean
C0021430 (UMLS CUI [1,1])
C1705116 (UMLS CUI [1,2])
Patient Information Unsuccessful
Item
it is impossible to correctly inform the patient
boolean
C1955348 (UMLS CUI [1,1])
C1272705 (UMLS CUI [1,2])
Lacking Able to read French language
Item
the patient cannot read french
boolean
C0332268 (UMLS CUI [1,1])
C0586740 (UMLS CUI [1,2])
C0376246 (UMLS CUI [1,3])
Diabetes Mellitus, Non-Insulin-Dependent
Item
the patient has a known history of type 2 diabetes
boolean
C0011860 (UMLS CUI [1])
Non-Insulin-Dependent Diabetes Mellitus During Pregnancy | Fasting blood glucose measurement
Item
the patient is diagnosed with type 2 diabetes during pregnancy (fasting blood glucose level > 1.26 g/l)
boolean
C0011860 (UMLS CUI [1,1])
C0347984 (UMLS CUI [1,2])
C0032961 (UMLS CUI [1,3])
C0428568 (UMLS CUI [2])
Medical contraindication Investigational Therapy
Item
the patient has a contra-indication for a treatment necessary for this study
boolean
C1301624 (UMLS CUI [1,1])
C0949266 (UMLS CUI [1,2])
Adrenal Cortex Hormones Oral chronic | Adrenal Cortex Hormones Oral Intermittent | Adrenal Cortex Hormones by Inhalation chronic | Adrenal Cortex Hormones by Inhalation Intermittent
Item
the patient is taking chronic or intermittent oral or inhaled corticosteroids, or a
boolean
C0001617 (UMLS CUI [1,1])
C1527415 (UMLS CUI [1,2])
C0205191 (UMLS CUI [1,3])
C0001617 (UMLS CUI [2,1])
C1527415 (UMLS CUI [2,2])
C0205267 (UMLS CUI [2,3])
C0001617 (UMLS CUI [3,1])
C0205535 (UMLS CUI [3,2])
C0205191 (UMLS CUI [3,3])
C0001617 (UMLS CUI [4,1])
C0205535 (UMLS CUI [4,2])
C0205267 (UMLS CUI [4,3])
Agonist Disease Previous | Disease Newly Diagnosed During Pregnancy | Glucose measurement, fasting | Oral Glucose Tolerance Test
Item
β2 agonist treatment for a previous disease or a disease discovered during pregnancy within one week preceding the fasting glucose or oral glucose tolerance test.
boolean
C2987634 (UMLS CUI [1,1])
C0012634 (UMLS CUI [1,2])
C0205156 (UMLS CUI [1,3])
C0012634 (UMLS CUI [2,1])
C1518321 (UMLS CUI [2,2])
C0347984 (UMLS CUI [2,3])
C0032961 (UMLS CUI [2,4])
C0202045 (UMLS CUI [3])
C0029161 (UMLS CUI [4])